NASDAQ:CBLI
Delisted
Cleveland BioLabs Stock News
$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022
14 Biotechnology Stocks Moving In Monday's Pre-Market Session
12:38pm, Monday, 27'th Jan 202023 Biotechnology Stocks Moving In Monday's After-Market Session
12:00am, Monday, 27'th Jan 2020'Possible coronavirus case at a Tennessee university as death toll rises in China' -Charlotte Observer
12:00am, Friday, 24'th Jan 2020A History Of Coronavirus Outbreaks And The Stock Market
12:00am, Wednesday, 22'nd Jan 2020The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
12:00am, Tuesday, 19'th Nov 2019What Kind Of Investor Owns Most Of Cleveland BioLabs, Inc. (NASDAQ:CBLI)?
11:58am, Monday, 18'th Nov 2019
A look at the shareholders of Cleveland BioLabs, Inc. (NASDAQ:CBLI) can tell us which group is most powerful...
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
12:00am, Friday, 15'th Nov 2019Cleveland BioLabs Reports Third Quarter 2019 Financial Results and Development Progress
09:30pm, Thursday, 14'th Nov 2019
BUFFALO, NY / ACCESSWIRE / November 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the third quarter ended September 30, 2019. Cleveland
